
|Articles|September 1, 2003
Safer treatment option, with less risk of infection, available to hemophiliacs
Baxter launches Advate for hemophiliacs
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
4
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
5


























































































































































